|
US2016074315A1
|
|
Topical cosmetic skin lightening compositions and methods of use thereof
|
|
US2016074316A1
|
|
Topical cosmetic skin lightening compositions and methods of use thereof
|
|
WO2014182655A1
|
|
Assay for screening a compound for the ability to modulate proinflammatory cytokine production in human skin
|
|
CN105338950A
|
|
Non-aqueous solid stabilized emulsions
|
|
WO2013181487A2
|
|
Method of treating
|
|
BR112012001680A2
|
|
Tazarotene derivatives
|
|
US2010210571A1
|
|
Topical formulations for treatment of skin disorders
|
|
EA022569B1
|
|
Fatty acid monoglyceride compositions
|
|
US2011163108A1
|
|
Container venting disc
|
|
WO2010068296A1
|
|
Piperazine carboxamidines as antimicrobial agents
|
|
AU2009223833A1
|
|
Processes for preparing enantiomerically pure diol and dioxolane compounds
|
|
AU2008364312A1
|
|
Topical cosmetic skin lightening compositions
|
|
MX2010005549A
|
|
Topical cosmetic skin lightening compositions.
|
|
AU2007361455A1
|
|
Topical cosmetic skin lightening compositions and methods of use thereof
|
|
WO2008057411A1
|
|
Kits containing benzoyl peroxide pads and another acne-treating composition, and formulations and methods of use therefor
|
|
WO2008057423A1
|
|
Kits containing benzoyl peroxide pads and a barrier repair composition, and formulations and methods of use therefor
|
|
BRPI0718577A2
|
|
Reticulated hyaluronic acid and preparation process
|
|
BRPI0718310A2
|
|
Talarozol metabolites
|
|
WO2007094999A2
|
|
Ungual antifungal compositions
|
|
WO2007092312A2
|
|
Topical skin treating compositions
|
